It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest in the drugmaker hasn’t dampened much.Earlier this month, US-...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
Daily, weekly and monthly curated newsletters on the deal ecosystem in India
Breaking news alerts
Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced